VRTX

$498.50 · +2.7% today · −1.4% 5d · +2.6% 3m · +22.4% 1y

Daily score87
Weekly score57
Long-term score70

Close

Scores (0–100)

Components — latest (2026-10-14)

Close

498.50

1D return

+2.7%

5D return

−1.4%

Rel volume

1.94

CMF 20

-0.10

OBV slope 20

-0.02

Up-vol ratio 10

0.37

Short ratio

0.40

Short ratio Δ

−16.1%

Persistence 10

1.00

Inflow mean 5d

0.01

Inflow mean 60d

0.19

Momentum 12-1

+26.3%

% of 52w high

+89.3%

vs 200d

+4.9%

Volatility 60d

+27.3%

Dollar vol 20d

$586.66M

Insider buys 90d

$0

Insider buyers 90d

0.00

Revenue growth

+12.5%

Fundamentals — Vertex Pharmaceuticals · Health Care

as of 2026-10-22
P/E
34.3
P/B
6.70
ROE
19.5%
Operating margin
34.8%
Debt / equity
0.00
FCF yield
2.4%
Years profitable
4/5
BM score
57
Moat flag
No

Insider trades (Form 4)

FiledInsiderTitleTypeSharesPriceValue
2026-07-07McKechnie DuncanEVP, Chief Commercial OfficerSell1.5K$519.00$799.8K
2026-07-07Tatsis OuraniaEVP, Chief Reg. & Quality Off.Sell1.5K$524.99$787.5K
2026-07-06Liu JoyEVP and Chief Legal OfficerSell828$502.71$416.2K
2026-06-30Bozic CarmenEVP and CMOSell596$482.50$287.6K
2026-06-23Bozic CarmenEVP and CMOSell1.0K$462.17$471.4K
2026-06-17Bozic CarmenEVP and CMOSell4.1K$450.00$1.83M
2026-06-09Bozic CarmenEVP and CMOSell1.7K$450.00$785.3K
2026-06-03Liu JoyEVP and Chief Legal OfficerSell828$439.91$364.2K
2026-06-02Bozic CarmenEVP and CMOSell2.0K$450.00$888.3K
2026-05-19Bunnage Mark E.EVP, Chief Scientific OfficerSell33$453.45$15.0K
2026-05-19Bozic CarmenEVP and CMOSell1.4K$453.45$614.0K
2026-05-14Bozic CarmenEVP and CMOSell7.0K$450.00$3.14M
2026-05-05Bhatia Sangeeta N.DirectorSell318$423.73$134.7K
2026-05-05Liu JoyEVP and Chief Legal OfficerSell1.1K$425.02$469.2K

Congress trades

FiledTradedMemberTypeOwnerAmountLagSource
2026-09-052026-08-26David J. Taylor (OH02)SaleSelf$1,001 - $15,00010PDF
2026-02-022026-01-29David J. Taylor (OH02)SaleSelf$1,001 - $15,0004PDF
2026-01-132024-10-23Julia Letlow (LA05)PurchaseSelf$1,001 - $15,000447PDF

Source: U.S. House Clerk periodic transaction reports (STOCK Act). Disclosures lag trades.